Phase 1 Malignant Melanoma trials recruiting now
All Malignant Melanoma trials, every phase
9
Phase 1 recruiting
Other phases for Malignant Melanoma
Phase 1 Malignant Melanoma trials
- A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
- AMT-253 in Patients With Advanced Solid Tumours
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
- GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
- Modified Vaccine for High Risk or Low Residual Melanoma Patients
- RAPA-201 Therapy of Solid Tumors
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
Common questions
What does Phase 1 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.